Haoxi Health Technology LtdHAO
Price (close)
$2.97
Market cap
—
P/E
—
Revenue (FY)
$32.8M
Net income
$3.9M
Dividend yield
—
1-year total return
-99.9%
Net margin
11.8%
Revenue growth
-32.4%
Debt / equity
0.11x
What Haoxi Health Technology Ltd does.
provider in China, with an advertiser client base mainly in the healthcare industry. The growth of the operating entity in recent years
has benefited from the quick increase of news feed ads, its major form of ad placement, in the industry of online marketing in China.
In addition, the healthcare industry in China has developed rapidly because of the growth both in the average income and the aging population,
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | $16.2M | $28.2M | $48.5M | $32.8M |
| Net income | — | $244,587 | $969,752 | $1.3M | $3.9M |
| Free cash flow | — | -$684,059 | -$917,632 | -$802,943 | — |
More on HAO.
- Haoxi Health Technology Ltd summary
- Haoxi Health Technology Ltd financial statements
- Haoxi Health Technology Ltd key metrics
- Haoxi Health Technology Ltd health scores and style box
- Haoxi Health Technology Ltd earnings
- Haoxi Health Technology Ltd dividends
- Haoxi Health Technology Ltd valuation
- Haoxi Health Technology Ltd ownership and insiders
- Haoxi Health Technology Ltd peers
Figures from Haoxi Health Technology Ltd's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.